Mengxuan Cao

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Coronary Artery Bypass

End Stage Renal Disease

Gas Chromatography

Top Venues

Journal of oncology

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Si-Wei Pan, Mengxuan Cao, Can Hu, Yanqiang Zhang, Yian Du, Zhiyuan Xu, Xiangdong Cheng
A Novel Method for Dynamically Assessing the Prognosis of Patients with pT1 Gastric Cancer: A Large Population-Based Dynamic Prognostic Analysis. Journal of oncology 2023 (2023)
Si-Wei Pan, Mengxuan Cao, Can Hu, Yanqiang Zhang, Yian Du, Zhiyuan Xu, Xiangdong Cheng
A Novel Method for Dynamically Assessing the Prognosis of Patients with pT1 Gastric Cancer: A Large Population-Based Dynamic Prognostic Analysis. Journal of oncology 2023 (2023)
Pengcheng Yu, Weiyang He, Yanqiang Zhang, Xiang-Dong Cheng, Yue Wu, Yi Wang, Zhehan Bao, Yuhang Xia, Ruolan Zhang, Mengxuan Cao, Li Yuan, Xiang-Dong Cheng, Zhiyuan Xu
SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer. Journal of oncology 2022 (2022)
Jielu Cao, Can Hu, Jingli Xu, Jing Han, Ruolan Zhang, Mengxuan Cao, Li Yuan, Zhi-Yuan Xu
Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)